dc.relation.reference | 1. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York city. An anlysis by DNA fingerprinting and conventional epidemiologic methods N Engl J Med 1994;330:1710-6.
2. American Thoracic Society. Control of tuberculosis in the United States. Am Rev Respir Dis 1992;146:1623-1633.
3. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-1395.
4. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000; 161: S221-S247.
5. American Thoracic Society. Treatment of tuberculosis and tuberculous infection in adults and children. Am Rev Respir Dis 1986;134:355-363.
6. Armitage P, G. Berry G. Statistical Methods in Medical Research. Blackwell Science Ltd;2002.
7. Bailey WC, Gerald LB, Kimerling ME, Redden D, Brook N, Bruce F et al. Predictive Model to Identify Positive Tuberculosis Skin Test Results During Contact Investigations. JAMA 2002;287:996-1002.
8. Barnes PF, Cave MD. Molecular epidemiology of tuberculosis. N Engl J Med 2003; 349(12):1149-56.
9. Barnes PF, Yang Z, Pogoda JM, Preston-Martin S, Jones BE, Otaya M. Foci of tuberculosis transmission in central Los Angeles. Am J Respir Crit Care Med 1999;159:1081–1086.
10. Barnes PF, Yang Z, Preston-Martin S. Patterns of tuberculosis transmission in central Los Angeles. JAMA. 1997;278:1159-1163.
11. Barnes PF. Reducing ongoing transmission of tuberculosis. JAMA. 1998;280:1702-1703.
12. Barr RG, Diez-Roux AV, Knirsch CA, Pablos-Mendez A. Neighborhood poverty and the resurgence of tuberculosis in New York city, 1984-1992. Am J Public Health 2001; 91:1487-1493.
13. Behr MA, Hopewell PC, Paz EA, Kawamura LM, Schecter GF, Small PM. Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis Am J Respir Crit Care Med 1998;158:465–469.
14. Behr MA, Warren SA, et al. Transmission of mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999;353: 444-49.
15. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey M, et al. Origin and interstate spread of a New York city multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996; 275:452-457.
16. Bishai WR, Graham NMH, Harrington S. Molecular and geographic patterns of tuberculosis after 15 years of directly observed therapy. JAMA 1998; 280:1679-1684.
17. Bleiker MA, Sutherland I, Styblo K et al. Guidelines for estimating the risks of tuberculosis infection from tuberculin test results in representative sample of children. Bull Int Union Tuberc Lung Dis 1989;64(2):7-12.
18. Bloom BR, Murry CJL. Tuberculosis: commentary on a reemergent killer. Science 1992;257:1055-1063.
19. Blower SM, Mclean AR, Porco TC, Small PM, Hopewell PC, Sanchez MA, Moss AR. The intrinsic transmission dynamics of tuberculosis epidemics. Nature Medicine 1995;8:815-821.
20. Borgdorff MW, Floyd K, Broekmans JF. Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries. Bull World Health Organ 2002;80:217-227.
21. Bowerman RJ. Tuberculin skin testing in BCG-vaccinated populations of adults and children at high risk for tuberculosis in Taiwan. Int J Tuberc Lung Dis 2004;8(10):1228–1233.
22. Braden CR, Templeton GL, Cave MD, Valway S, Onorato IM, Castro KG. Interpretation of restriction fragment length polymorphism analysis of mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis 1997;175:1446-52.
23. Bradford WZ, Koehler J, El-Hajj H, Hopewell PC, Reingold AL, Agasino CB, et al. Dissemination of Mycobacterium tuberculosis across the San Francisco Bay Area. J Infect Dis 1998; 177:1104-1107.
24. Breslow NE, Day NE. Statistical methods in cancer research. Volume II. The design and analysis of cohort study. Lyon, France. International Agency for Research on Cancer publication; 1987.
25. Casper C, Singh SP, Rave S, Daley CL, Schecter GS, Riley LW, et al. The transcontinental transmission of tuberculosis: A molecular epidemiological assessment. Am J Public Health 1996; 86:551-553.
26. Cauthen GM, Pio A, ten Dam HG. Annual risk of tuberculosis infection. World Health Organization Document 1988;WHO/TB/88.154:1-34.
27. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of mycobacterium tuberculosis in healthcare facilities. MMWR 1994;43(No. RR-13)
28. Centers for Disease Control and Prevention. Tuberculosis Morbidity: United States, 1992. MMWR 1993;42(36):696-697,703-704.
29. Centers for Disease Control and Prevention. Tuberculosis Morbidity -- United States, 1997. MMWR 1998; 47(13):253-257
30. Center for Disease Control Taiwan, Department of Health. http://www.cdc.gov.tw/e/aids, Accessed 2004.
31. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of mycobacterium tuberculosis in health-care facilities, 1994. MMWR 1994;43:RR-13.
32. Centers for Disease Control and Prevention. Recommendations for prevention and control of tuberculosis among foreign-born persons. Report of the Working Group on Tuberculosis among Foreign-Born Persons. MMWR Morb Mortal Wkly Rep 1998;47(RR-16):1-29.
33. Chan-Yeung M, Tam CM, Wong H, et al. Molecular and conventional epidemiology of tuberculosis in Hong Kong: a population-based prospective study. J Clin Microbiol 2003;41(6):2706-8.
34. Chee CBE, Soh CH, Boudville IC et al. Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren. Am J Respir Crit Care Med 2001;164:958-961.
35. Cheng AT, Chen WJ. Alcoholism among four aboriginal groups in Taiwan: high prevalences and their implications. Alcohol Clin Exp Res 1995; 19:81-91.
36. Chiang CY, Wu IH, Yu MC, LeeCN, Bai KJ, Suo J, Lin TP. Screening of human immunodeficiency virus infection in pulmonary tuberculosis patients in Taiwan. J Formos Med Assoc 1998;97:66-8.
37. Chiang IH, Yu MC, Bai KJ, Wu MP, Hsu CJ, Lin TP, Luh KT. Drug resistance patterns of tuberculosis in Taiwan. J Formos Med Assoc. 1998;97:581-3.
38. China Tuberculosis Control Collaboration. Results of directly observed short-course chemotherapy in 112842 Chinese patients with smear-positive tuberculosis. Lancet 1996;347:358-62.
39. Chou Sung-Ching. An epidemiological study on tuberculosis disease: what can we learn from the Taiwan Provincial Chronic Disease Control Bureau (TPCDCB) cohort. 1998.
40. Cohn DL, El-Sadr. Treatment of latent tuberculosis infection. In: Reichman LB, Hershfield ES, ed. Tuberculosis: a comprehensive international approach, New York: Marcel Dekker, 2000: 471-502.
41. Cohn DL, O’Brien RJ. The use of restriction fragment length polymorphism (RFLP) analysis for epidemiological studies of tuberculosis in developing countries. Int J Tuberc lung dis 1998; 2(1):16-26.
42. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA1994;271:698-702.
43. Colice GL. Decision analysis, public health policy, and isoniazid chemoprophylaxis for young adult tuberculin skin reactors. Arch Intern Med 1990;150:2517–2522.
44. Collett D. Modeling survival data in medical research. London: Chapman & Hall;1994.
45. Comstock GW, Edwards LB, Nabangxang H. Tuberculin sensitivity eight to fifteen years after BCG vaccination. Am Rev Respir Dis 1971;103(4):572-5.
46. Comstock GW, Edwards PQ. The competing risks of tuberculosis and hepatitis for adult tuberculin reactors. Am Rev Respir Dis 1975; 111:573-577.
47. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99:131-138.
48. Comstock GW, O’Brien RJ. Tuberculosis. In: Evans AS, Brachman PS, ed. Bacterial Infection of Human: epidemiology and control, New York: Plenum publishing corporation, 1998:777-804.
49. Comstock GW. Epidemiology of tuberculosis. In: Reichman LB, Hershfield ES, ed. Tuberculosis: a comprehensive international approach, New York: Marcel Dekker, 2000:129-156.
50. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ. 1994;72:213-220.
51. Du SM. The progress of medical care after world war II in Taiwan. Journal of Formosan Medical Association 1952;51:1-5.(杜聰明:第45屆總會開會致辭-光復後台灣醫學之進展,台灣醫學會雜誌;第51卷,第12號:591-595)
52. Dye C, Garnett GP, Sleeman K, Williams BG. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Lancet 1998;352:1886-91.
53. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M. Global burden of buberculosis: estimated incidence, prevalence, and mortality by country. JAMA 1999;282:677-686.
54. Dye C, Watt CJ, Bleed D. Low access to a highly effective therapy: a challenge for international tuberculosis control. Bulletin of the World Health Organization 2002;80:437-444.
55. Etkind SC, Veen J. Contact follow-up in high- and low-prevalence countries. In: Reichman LB, Hershfield ES, ed. Tuberculosis: a comprehensive international approach, New York: Marcel Dekker, 2000:377-399.
56. Fine PEM, Small PM. Exogenous reinfection in tuberculosis. N Engl J Med 1999; 341:1226-1227.
57. Fine PEM. Bacille Calmette-Guerin vaccines: a rough guide. Clin Infect Dis 1994;20:11-14.
58. Fine PEM. BCG Vaccines and Vaccination. In: Reichman LB, Hershfield ES, ed. Tuberculosis: a comprehensive international approach, New York: Marcel Dekker, 2000:503-522.
59. Fine PEM. Variation in protection by BCG: implication of and for heterologous immunity. Lancet 1995;346:1339-45.
60. Fitzgerald JM, Wang L, Elwood RK. Tuberculosis:13.Control of the disease among aboriginal people in Canada. CMAJ 2000; 162:351-355.
61. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York-turning the tide. N Engl J Med 1995;333:229-33.
62. Fu YC. Ethnic Enclosure and Ingroup Favoritism among Taiwan's Indigenous Peoples. Paper presented at 2000 International Conference on the Policy of Urban Indigenous Peoples. Taipei. 2000.
63. Garcia-Garcia M, Palacios-Martinez M, Ponce-de-Leon A et al. The role of core groups in transmitting Mycobacterium tuberculosis in a high prevalence community in Southern Mexico. Int J Tuberc Lung Dis 2000; 4(1):12-7.
64. Gaudette LA, Ellis E. Tuberculosis in Canada: a focal disease requiring distinct control strategies for different risk groups. Tubercle Lung Dis 1993; 74:244-253.
65. Genewein A, Telenti A, Mordasini C, et al. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 1993;342:841-44.
66. Halloran ME. Concepts of infectious disease epidemiology. In: Rothman KJ, Greenland S, ed. Modern epidemiology, Philadelphia: Lippincott-Raven, 1998:529-554.
67. Hermans PW, Messadi F, Guebrexabher H, van Soolingen D, de Haas PE, Heersma H, et al. Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J Infect Dis. 1995; 171:1504-1513.
68. Heymann SJ, Brewer TF, Wilson ME, Fineberg HV. The need for global action against multidrug-resistant tuberculosis. JAMA 1999;281(22):2138-2140.
69. Horsburgh CR. The global problem of multidrug-resistant tuberculosis: the genie is out of the bottle. JAMA 2000;283:2575-2576.
70. Hsieh SM, Hung CC, Chen MY, Chang SC, Hsueh PR, Luh KT, Chuang CY. Clinical features of tuberculosis associated with HIV infection in Taiwan. J Formos Med Assoc 1996;95:923-8.
71. Huang XZ, Lin WD. Analysis of the utilization of medical care in remote areas in Taiwan. Taipei. Bureau of National Health Insurance; 1997.
72. Huebner RE, Schein MF, Bass JB. The tubercukin skin test. Clin Infect Dis. 1993;17:968-975.
73. Ildirim I, Hacimustafaoglu M, Ediz B. Correlation of tuberculin induration with the number of Bacillus Calmette-Guerin vaccines. Pediatr Infect Dis J 1995;14(12):1060-3.
74. Jian Yang. Tuberculosis Epidemiology in Aboriginal Mountain Areas in Taiwan, 2000.
75. Kline SE, Hedemark LL, Davies SF. Outbreak of tuberculosis among regular patrons of a neighborhood bar. N Engl J Med 1995; 333:222-227.
76. Klovdahl AS, Graviss EA, Yaganehdoost A, Ross MW, Wanger A, Adams GJ, et al. Networks and tuberculosis: an undetected community outbreak involving public places. Soc Sci Med 2001; 52:681-694.
77. Ko YC, Hsieh SF. Leading causes of death in the aborigines in Taiwan. Kaohsiung Journal of Medical Sciences 1994; 10:352-366.
78. Ko YC, Liu BH, Hsieh SF. Issues on aboriginal health in Taiwan. Kaohsiung Journal of Medical Sciences 1994; 10:337-351.
79. Lauzardo M, Hollender ES, Narita M, Ashkin D, Lantana.Who Dunnit? The Changing Face of Tuberculosis Control Utilizing Restriction Fragment Length Polymorphism.CHEST 2001;120(6):1765-1767.
80. Lin TM, Chao SL, Luan HW, Chen KP. An analytical study on the mortality and prevalence rates of pulmonary tuberculosis in the aboriginal area in Taiwan. J Formosan Med Assoc 1980; 80:359-368.
81. Lipsitch M, Levin BR. Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance. Int J Tuberc Lung Dis 1998;2(3):187-199.
82. Lockman S, Sheppard JD, Braden CR, et al. Molecular and conventional epidemiology of mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients. J Clin Microbiol 2001;39(3):1042-7.
83. Long R, Njoo H, Hershfield E. Tuberculosis: 3. epidemiology of the disease in Canada. CMAJ 1999;160:1185-1190.
84. Long-Teng L, Chien-Jen C, Shut-Fang T, Jen S, Ching-Yu C. Morbidity and mortality trends of pulmonary tuberculosis in Yaiwan. J Formos Med Assoc 1992;91:867-72.
85. Long-Teng L, Chien-Jen C, Wen-Chung L, Kwen-Tay L, Wei-Chuan H, Ruey-Shiung L. Age-period-cohort analysis of pulmonary tuberculosis mortality in Taiwan: 1961-1990. J Formos Med Assoc 1994;93:657-62.
86. Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH. Outcomes of Contact Investigations of Infectious Tuberculosis Patients. Am J Respir Crit Care Med 2000;162:2033–2038.
87. Menzies D. Effect of treatment on contagiousness of patients with active pulmonary tuberculosis. Infect Control & Hospital Epi. 1997;18(8):582-6.
88. Menzies R, Vissandjee B, Amyot D. Factors associated with tuberculin reactivity among the foreign-born in Montreal. Am Rev Respir Dis 1992;146(3):752-6.
89. Menzies R, Vissandjee B. Effect of Bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992;145:621-625.
90. Menzies RI. Tuberculin skin testing. In: Reichman LB, Hershfield ES, ed. Tuberculosis: a comprehensive international approach, New York: Marcel Dekker, 2000:279-322.
91. Migliori GB, Ambrosetti M, Besozzi G, Casali L, Riviglione MC and the National AIPO Tuberculosis Study Group. Prospective multicenter study on the evaluation of anti-tuberculosis treatment results in Italy:comparison of the culture- versus the smear-based methods. Eur Respir J 1999;13:900-903.
92. Mohle-Boetani JC, Flood J. Contact Investigations and the Continued Commitment to Control Tuberculosis. JAMA 2002;287:1040-1042.
93. Moreno S, Blazquez R, Novoa A et al. The effect of BCG vaccination on tuberculin reactivity and the booster effect among hospital employees. Arch Intern Med 2001;161(14):1760-5.
94. Murray M, Nardell E. Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge. Bull World Health Organ 2002;80(6):477-82.
95. Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH. Manual of Clinical Microbiology, seventh edition. American Society for Microbiology;2003.
96. Murry CJL, Salomon JA. Using mathematical models to evaluate global tuberculosis control strategies. Proc Natl Acad Sci USA 1998;95:13881-13886. Also on http://www.hsph.harvard.edu/organizations/bdu/papers/gtcs/ummegtcs.html
97. Murry CJL, Salomon JA. Expanding the WHO tuberculosis control strategy: rethinking the role of active case-finding Int J Tuberc Lung Dis 1998;2(9):S9–S15.
98. Murry CJL, Styblo K, Rouillon A. Tuberculosis. In:Jamison D,Mosley WH,Measham AR,Bodadilla JB, ed. Disease Control Priorities in Developing Countries. Oxford:Oxford University Express.1993:233-259.
99. Murry CJL. Issues in operational, social, and economic research on tuberculosis. In: Bloom BR, ed. Tuberculosis: pathogenesis, protection, and control. Washington, DC: ASM press. 1994:583-622.
100. Nardel EA, Piessens WF. Transmission of tuberculosis. In: Reichman LB, Hershfield ES, ed. Tuberculosis: a comprehensive international approach, New York: Marcel Dekker, 2000:215-240.
101. Nardell EA, Brickner PW. Tuberculosis in New York city: focal transmission of an often fatal disease. JAMA 1996; 276:1259-1260.
102. Nolan C M, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA 1999;281:1014–1018.
103. Pablos-Méndez A, Raviglione MC, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med. 1998;338:1641-1649.
104. Park YK, Bai GH, Kim SJ. Restriction fragment length polymorphism analysis of mycobacterium tuberculosis isolated from countries in the western pacific region. J Clin Microbiol 2000;38(1):191-7.
105. Pfyffer GE, Funke-Kissling P, Rundler E, Weber R. Performance characteristics of the BDProbeTec system for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol 1999;37:137-140.
106. Raviglione MC, Dye C, Schmidt S, Kochi A. Assessment of worldwide tuberculosis control. Lancet 1997; 350: 624-29.
107. Raviglione MC, Snider DE, Kochi A. Global Epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995;273:220-226.
108. Reichler MR, Reves R, Thompson V, Mangura BT, Ford J, Valway SE, Onorato IM. Evaluation of Investigations Conducted to Detect and Prevent Transmission of Tuberculosis. JAMA. 2002;287:991-995.
109. Rieder HL. Epidemiologic basis of tuberculosis control. Paris: IUATL, 1999.
110. Rodrigues L, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculosis meningitis and military tuberculosis: a meta-analysis. Int J Epidemiol 1993;22:1154-1158.
111. Rothman KJ, Greenland S. Modern Epidemiology. 2nd edition. Philadelphia. Lippincott-Raven Publishers; 1998.
112. Sahai H, Khurshid A. Statistics in epidemiology. Florida: CRC Press;1996.
113. Salpeter EE, Salpeter SR. Mathematical model for the Epidemiology of tuberculosis, with estimates of the reproductive number and infection-delay function. Am J Epidemiol 1998;142:398-406.
114. Salpeter SR, Sanders GD, Salpeter EE, Owens DK. Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis. Ann Intern Med 1997;127:1051-1061.
115. Schwartzman K, Menzies D. Tuberculosis screening of immigrants to low-prevalence countries. Am J Respir Crit Care Med 2000;161:780-789.
116. Sepulveda RL, Ferrer X, Latrach C et al. The influence of Calmette-Guerin Bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am Rev Respir Dis 1990;142:24-28.
117. Sepulveda RL, Gonzalez B, Gerszencveig R et al. The influence of BCG immunization on tuberculin reactivity in healthy Chilean women in the third trimester of pregnancy. Tuber Lung Dis 1995;76(1):28-34.
118. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994;330:1703-9.
119. Small PM. Towards an understanding of the global migration of mycobacterium tuberculosis. J Infect Dis. 1995;171:1593-4.
120. Smith PG, Moss AR. Epidemiology of tuberculosis. In: Bloom BR, ed. Tuberculosis: pathogenesis, protection, and control. Washington, DC: ASM press. 1994:47-59.
121. Sterne JAC, Rodrigues LC, Guedes IN. Dose the efficacy of BCG decline with time since vaccination? Int J Tuberc Lung Dis1998;2(3):200-207.
122. Suo J, Hwang G. A review of BCG vaccination in Taiwan: Policies and Practice. Chronic Disease Control News. 1998;45:5-12. (索任、黃菊:台灣地區卡介苗預防接種工作之回顧,慢性病防治通訊;第45期:5-12,1998.9.10.)
123. Suo J, Yu MC, Lee CN, Chiang CY, Lin TP. Treatment of multidrug-resistant tuberculosis in Taiwan. Chemotherapy 1996;42(suppl 3):20-23.
124. Taiwan, R.O.C. Center for Disease Control, Department of Health. Tuberculosis in Taiwan. http://203.65.72.83/ch/dt/upload/qc/epi/epi_face.htm. accessed in 2004.
125. Taiwan, R.O.C. Center for Disease Control, Department of Health. Tuberculosis annual report 2001. Taipei. Center for Disease Control;2002.
126. Taiwan, R.O.C. Council of Indigenous Affairs, the Executive Yuan. Statistics of Indigenous Population in Taiwan and Fukien Areas. 1997. http://www.apc.gov.tw/official/
127. Taiwan, R.O.C. Department of Health. White book of Public Health. 1997. http://www.doh.gov.tw/lane/publish/white-paper/Welcome.html
128. Taiwan, R.O.C. Ministry of the Interior. Taiwan-Fukien-Demographic Fact Book. Taipei. Ministry of the Interior; 1991-1997.
129. Taiwan Provincial Chronic Disease Control Bureau.. Manual of BCG Vaccination and Tuberculin Skin Testing. Taipei. Taiwan Provincial Tuberculosis Control Bureau; 1999.
130. Taiwan Provincial Tuberculosis Control Bureau. TB control in Taiwan: 1976-1981.Taipei. Taiwan Provincial Tuberculosis Control Bureau;1981.
131. Taiwan Provincial Chronic Disease Control Bureau. TB statistics: 1997. Taipei. Taiwan Provincial Tuberculosis Control Bureau; 1999.
132. Taiwan Provincial Chronic Disease Control Bureau. TB statistics: 1998. Taipei. Taiwan Provincial Tuberculosis Control Bureau; 1999.
133. Taiwan Provincial Chronic Disease Control Bureau. TB Statistics: 1999. Taiwan Provincial Tuberculosis Control Bureau; 2001.
134. Tao JC. Preliminary report: tuberculosis control work among schoolchildren in Taiwan, J Formos Med Assoc 1951;50(1-2):1-11.
135. U.S. Division of TB Elimination. Centers for Disease Control and Prevention, Reported Tuberculosis in the United States, 2001. Available from: URL: www.cdc.gov/nchstp/tb.
136. van Embden JDA, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendation for a standardized methodology. J Clin Microbiol 1993;31:406-9.
137. van Rie A et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999; 341:1174-9.
138. van Soolingen D, Qian L, de Haas PEW, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 1995;33(12):3234-8.
139. Veen J. Microepidemics of tuberculosis: the stone-in-the-pond principle. Tuber Lung Dis 1992;73(2):73-76.
140. Verver S, Warren RM, Munch Z. Transmission of tuberculosis in a high incidence urban community in South Africa. Int J Epidemiol 2004;33(2):351-7.
141. Vynnycky E, Fine PEM. Interpreting the decline in tuberculosis: the role of secular trends in effective contact. Inter J Epi 1999;28:327-334.
142. Vynnycky E, Fine PEM. Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epi 2000;152:247-63.
143. Vynnycky E, Fine PEM. The natural history of tuberculosis: the implication of age-dependent risks of disease and the role of reinfection. Epidemiol. Infect. 1997;119:183-201.
144. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 2002;57(9):804-809.
145. Wilkinson D, Pillay M, Crump J, et al. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural Africa. Trop Med Int Health 1997;2(8):747-53.
146. World health organization. Global Tuberculosis Control. WHO report. 1999.
147. World health organization. Treatment of tuberculosis: guidelines for national programmes. 2003. WHO/CDS/TB 2003.313
148. World Health Organization. What is DOTS? A guide to understanding the WHO-recommanded TB control strategy known as DOTS. 1999.
149. Yeh YP, Chang HJ, Yang J, Chang SH, Suo J, Chen T HH. Incidence of Tuberculosis in Mountain Areas and Surrounding Townships: Dose-response Relationship by Geographic Analysis. Ann Epidemiol in press.
150. Yu MC, Suo J, Chiang CY, Bai KJ, Lin TP, Luh KT. Initial drug resistance of mycobacterium tuberculosis in Taiwan. J Formos Med Assoc. 1997;96:890-4.
151. Zahrani KA, Jahdali HA, Menzies D. Dose size matter? Utility of size of tuberculin reactions for diagnosis of mycobacterial disease. Am J Respir Crit Care Med 2000;162:1419-1422. | zh_TW |